At this year’s Society of Nuclear Medicine meeting, imaging systems that fused PET with CT was a feature seen at a few vendor booths, including GE and SMV of Ohio. SMV displayed a combination PET/CT system called Positrace that was first seen at
At this years Society of Nuclear Medicine meeting, imaging systems that fused PET with CT was a feature seen at a few vendor booths, including GE and SMV of Ohio. SMV displayed a combination PET/CT system called Positrace that was first seen at last years RSNA meeting.
SMV anticipated that these two technologies belong together, said Lonnie Mixon, SMVs vice president of worldwide marketing.
The first Positrace system has been installed in France. SMV applied for a 510(k) for the system in May. It expects approval by the end of August.
The device uses specialized digital detectors in a hexagonal ring configuration with thick NaI crystals. Although the system looks like a single unit, the CT scanner is attached to the PET scanner on one end. The Positrace has a 50-cm axial view and a 70-cm patient aperture.
This reduces the claustrophobic sensation, Mixon said.
Meta-Analysis Shows Merits of AI with CTA Detection of Coronary Artery Stenosis and Calcified Plaque
April 16th 2025Artificial intelligence demonstrated higher AUC, sensitivity, and specificity than radiologists for detecting coronary artery stenosis > 50 percent on computed tomography angiography (CTA), according to a new 17-study meta-analysis.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.